13-Hydroxylabda-8(17),14-dien-18-oic acid

13-Hydroxylabda-8(17),14-dien-18-oic acid
Product Name 13-Hydroxylabda-8(17),14-dien-18-oic acid
CAS No.: 83915-59-7
Catalog No.: CFN97332
Molecular Formula: C20H32O3
Molecular Weight: 320.5 g/mol
Purity: >=98%
Type of Compound: Diterpenoids
Physical Desc.: Powder
Source: The herbs of Chloranthus elatior
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Reference standards.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Horticulturae2021, 7(1),5.
  • Evid Based Complement Alternat Med.2017, 2017:1401279
  • Biomed Sci Letters.2020, 26:319-326
  • J Herbmed Pharmacol.2018, 7(4):280-286
  • Pharmaceutics.2021, 13(2):187.
  • Cancer Manag Res.2019, 11:483-500
  • Pharmacol Res.2020, 161:105205.
  • J. Pharm. Res. Int.2022, 34(58): pp.1-14.
  • BMC Microbiol.2019, 19(1):78
  • Plants (Basel).2021, 10(6):1119.
  • Sclareol glycol

    Catalog No: CFN96701
    CAS No: 55881-96-4
    Price: Inquiry(manager@chemfaces.com)
    Sclareol

    Catalog No: CFN90249
    CAS No: 515-03-7
    Price: $40/20mg
    13-Epimanool

    Catalog No: CFN97997
    CAS No: 1438-62-6
    Price: Inquiry(manager@chemfaces.com)
    6alpha-Hydroxynidorellol

    Catalog No: CFN97701
    CAS No: 70387-38-1
    Price: Inquiry(manager@chemfaces.com)
    Elliotinol

    Catalog No: CFN99033
    CAS No: 10178-31-1
    Price: Inquiry(manager@chemfaces.com)
    8alpha-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate

    Catalog No: CFN97847
    CAS No: 117254-98-5
    Price: Inquiry(manager@chemfaces.com)
    8(17),12E,14-Labdatrien-20-oic acid

    Catalog No: CFN89102
    CAS No: 1639257-36-5
    Price: Inquiry(manager@chemfaces.com)
    12E,14-Labdadien-20,8beta-olide

    Catalog No: CFN89101
    CAS No: 1639257-37-6
    Price: Inquiry(manager@chemfaces.com)
    13-Hydroxylabda-8(17),14-dien-18-oic acid

    Catalog No: CFN97332
    CAS No: 83915-59-7
    Price: Inquiry(manager@chemfaces.com)
    4-Epicommunic acid

    Catalog No: CFN97334
    CAS No: 83945-57-7
    Price: Inquiry(manager@chemfaces.com)
    Agricultural and Biological Chemistry, 1983, 47(4):787-794.
    Microbial Transformation of Manool and (12Z)-Labda- 8(17),12,14-triene by Rhodococcus erythropolis JTS-131.[Reference: WebLink]
    Rhodococcus erythropolis JTS-131, a cis-abienol and sclareol transformable bacterium, converted manool and accumulated manoyl oxide in the culture broth.
    METHODS AND RESULTS:
    In the presence of metabolic inhibitors, 13β-hydroxylabda-8(17),14-dien-18-oic acid(13-Hydroxylabda-8(17),14-dien-18-oic acid) and its methylester (a new compound) were accumulated as the transformation products. This strain also transformed (12Z)-labda-8(17),12,14- triene and acqumulated (12Z)-labda-8(17),12,14-trien-18-al in the culture broth. In the presence of metabolic inhibitors, two compounds, (12Z)-labda-8(17),12,14-trien-18-ol and 4,18,19-trinor-3,4- seco-5-oxo-(12Z)-labda-8(17),12,14-trien-3-oic acid were accumulated.
    CONCLUSIONS:
    Based on the experiments on the degradation sequence, transformation pathways for these two labdanes by the bacterium are proposed.
    3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol

    Catalog No: CFN95123
    CAS No: 1221686-60-7
    Price: $398/5mg
    Torosachrysone 8-O-beta-gentiobioside

    Catalog No: CFN95131
    CAS No: 94356-13-5
    Price: $318/5mg
    3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al

    Catalog No: CFN95168
    CAS No: 1446447-97-7
    Price: $318/5mg
    Isophysalin G

    Catalog No: CFN95328
    CAS No: 152221-21-1
    Price: $368/5mg
    Euphorbia factor L25

    Catalog No: CFN95339
    CAS No: 303174-98-3
    Price: $368/5mg
    Quercetin 3,7-diglucoside

    Catalog No: CFN95408
    CAS No: 6892-74-6
    Price: $318/10mg
    10-Methoxygambogenic acid

    Catalog No: CFN95450
    CAS No: 2095102-72-8
    Price: $318/10mg
    Benzylpropyl acetate

    Catalog No: CFN95495
    CAS No: 7492-40-2
    Price: $318/5mg
    5-Hydroxy-4a,8-dimethyl-3-methylen-decahydroazuleno[6,5-b]furan-2(3H)-on

    Catalog No: CFN95522
    CAS No: 114579-31-6
    Price: $318/5mg
    New compound 19

    Catalog No: CFN95538
    CAS No: N/A
    Price: $413/5mg